12 Satraplatin PPTs View free & download

The SPARC Trial: Satraplatin in Patients With Androgen Independent Prostate Cancer That Has Failed First-Line Chemotherapy PowerPoint PPT Presentation

The SPARC Trial: Satraplatin in Patients With Androgen Independent Prostate Cancer That Has Failed First-Line Chemotherapy - CE-2. The SPARC Trial: Satraplatin in Patients With Androgen Independent ... 1-point increase in PPI from nadir. 2-point increase in PPI from nadir. Progression ...

CE-2. The SPARC Trial: Satraplatin in Patients With Androgen Independent ... 1-point increase in PPI from nadir. 2-point increase in PPI from nadir. Progression ...

| PowerPoint PPT presentation | free to download

NDA 21-801 Satraplatin Proposed Indication PowerPoint PPT Presentation

NDA 21-801 Satraplatin Proposed Indication - Satraplatin is indicated for the treatment of patients with androgen ... 2 (Discomforting) 258 (28.3) 1 (Mild) 327 (35.9) 0 (None) Number of patients (%) Pain ...

Satraplatin is indicated for the treatment of patients with androgen ... 2 (Discomforting) 258 (28.3) 1 (Mild) 327 (35.9) 0 (None) Number of patients (%) Pain ...

| PowerPoint PPT presentation | free to download

$Treatment Options for Docetaxel refractory patients PowerPoint PPT Presentation$

Treatment Options for Docetaxel refractory patients - A multicenter phase II study of abiraterone acetate (AA) in docetaxel pretreated castration-resistant prostate cancer (CRPC) patients (pts) [abstract 5047].

A multicenter phase II study of abiraterone acetate (AA) in docetaxel pretreated castration-resistant prostate cancer (CRPC) patients (pts) [abstract 5047].

| PowerPoint PPT presentation | free to download

Antonio Gonz PowerPoint PPT Presentation

Antonio Gonz - Title: PowerPoint Presentation Last modified by: Antonio Gonz lez Created Date: 1/1/1601 12:00:00 AM Document presentation format: Presentaci n en pantalla

Title: PowerPoint Presentation Last modified by: Antonio Gonz lez Created Date: 1/1/1601 12:00:00 AM Document presentation format: Presentaci n en pantalla

| PowerPoint PPT presentation | free to download

Prostate Cancer - Prostate Cancer

Prostate Cancer

| PowerPoint PPT presentation | free to view

Methods used to assess and report pain-related endpoints in NDA 21-801 PowerPoint PPT Presentation

Methods used to assess and report pain-related endpoints in NDA 21-801 - Methods used to assess and report pain-related endpoints in NDA 21-801 Ethan Basch, MD, MSc Center for Drug Evaluation and Research Disclosures Current position ...

Methods used to assess and report pain-related endpoints in NDA 21-801 Ethan Basch, MD, MSc Center for Drug Evaluation and Research Disclosures Current position ...

| PowerPoint PPT presentation | free to download

Targeted Therapy in Metastatic Prostate and Renal Cell Cancers PowerPoint PPT Presentation

Targeted Therapy in Metastatic Prostate and Renal Cell Cancers - ... 2b Plus Bevacizumab in Advanced Renal Carcinoma ... Prostate Cancer. Treatment Paradigms. Emerging Options in Castrate Metastatic Prostate Cancer (CMPC) ...

... 2b Plus Bevacizumab in Advanced Renal Carcinoma ... Prostate Cancer. Treatment Paradigms. Emerging Options in Castrate Metastatic Prostate Cancer (CMPC) ...

| PowerPoint PPT presentation | free to view

Genitourinary Tumors Poster Discussion PowerPoint PPT Presentation

Genitourinary Tumors Poster Discussion - ... synthesis results in a high response rate in castration refractory cancer (CRPC) ... in post-docetaxel castration refractory prostate cancer (CRPC) patients (pts) ...

... synthesis results in a high response rate in castration refractory cancer (CRPC) ... in post-docetaxel castration refractory prostate cancer (CRPC) patients (pts) ...

| PowerPoint PPT presentation | free to view

Office of Oncology Drug Products: Drug Product Reviews PowerPoint PPT Presentation

Office of Oncology Drug Products: Drug Product Reviews - Oncology Products. Division of Medical. Imaging and. Hematology Products. 4 ... Includes drugs/biologics reviewed in Office of Oncology Drug Products ...

Oncology Products. Division of Medical. Imaging and. Hematology Products. 4 ... Includes drugs/biologics reviewed in Office of Oncology Drug Products ...

| PowerPoint PPT presentation | free to view

Management of locally advanced & metastatic prostate cancer PowerPoint PPT Presentation

Management of locally advanced & metastatic prostate cancer - Management of locally advanced & metastatic prostate cancer Dr. Purvish. M. Parikh MD, DNB, PhD, FICP Professor & Head Department of Medical Oncology

Management of locally advanced & metastatic prostate cancer Dr. Purvish. M. Parikh MD, DNB, PhD, FICP Professor & Head Department of Medical Oncology

| PowerPoint PPT presentation | free to view

6th ESMO Patient Seminar ESMO CONFERENCE LUGANO ECLU PowerPoint PPT Presentation

6th ESMO Patient Seminar ESMO CONFERENCE LUGANO ECLU - Natural History, Screening, Early Diagnosis. No Diagnosis without Prognosis. ... 3. Level A evidence (probability for cure) surgery, EBRT, brachytherapy. 4. New HIFU. ...

Natural History, Screening, Early Diagnosis. No Diagnosis without Prognosis. ... 3. Level A evidence (probability for cure) surgery, EBRT, brachytherapy. 4. New HIFU. ...

| PowerPoint PPT presentation | free to view

PFS - Inter-rater reliability and internal consistency not applicable to PPI ... Linear mixed effects model of within. patient variationa. Region effect 1% Country ...

Inter-rater reliability and internal consistency not applicable to PPI ... Linear mixed effects model of within. patient variationa. Region effect 1% Country ...

| PowerPoint PPT presentation | free to download

Satraplatin PowerPoint PPT Presentations